Literature DB >> 7922512

Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert.

P Liberini1, E P Pioro, D Maysinger, A C Cuello.   

Abstract

The aim of the present study was to investigate the long-term effect of cortical infarction on the subhuman primate (Cercopithecus aethiops) basal forebrain. The lesion, carried out by cauterizing the pial blood vessels supplying the left fronto-parieto-temporal neocortex, induced retrograde degenerative processes within the ipsilateral nucleus basalis of Meynert. The morphometrical analysis revealed that significant shrinkage of cholinergic neurons and loss of neuritic processes were localized within the intermediate regions of the nucleus basalis. The average cross-sectional areas of choline acetyltransferase-immunoreactive neurons in the intermedio-ventral (Ch4iv) and intermedio-dorsal (Ch4id) nucleus basalis were decreased to 62.5 +/- 9.5 and 58.0 +/- 8.6%, respectively, of the sham-operated values. Although an apparent loss of Nissl-stained magnocellular neurons in Ch4iv and Ch4id was found by applying a quantitative analysis based on a perikaryal-size criterion, data obtained by the quantification of immunostained material failed to reveal any significant decrease of cholinergic cell density. Results are discussed in view of future application of this ischemic model to study processes of retrograde degeneration following cortical target removal and to assess potential neurotrophic and neuroprotective properties of pharmacologic agents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7922512     DOI: 10.1016/0006-8993(94)91897-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Experimental neurotrophic factor therapy leads to cortical synaptic remodeling and compensates for behavioral deficits.

Authors:  A C Cuello
Journal:  J Psychiatry Neurosci       Date:  1997-01       Impact factor: 6.186

2.  Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

Authors:  Sonia Boncristiano; Michael E Calhoun; Peter H Kelly; Michelle Pfeifer; Luca Bondolfi; Martina Stalder; Amie L Phinney; Dorothee Abramowski; Christine Sturchler-Pierrat; Albert Enz; Bernd Sommer; Matthias Staufenbiel; Mathias Jucker
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

3.  Basal forebrain magnocellular cholinergic systems are damaged in mice following neonatal hypoxia-ischemia.

Authors:  Frances J Northington; Panagiotis Kratimenos; Victoria Turnbill; Debra L Flock; Daniella Asafu-Adjaye; Raul Chavez-Valdez; Lee J Martin
Journal:  J Comp Neurol       Date:  2021-11-03       Impact factor: 3.028

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.